Foot Locker stock surges 11% as turnaround shows signs of life
Foot Locker is making gains under CEO Mary Dillon, who has been working to win back brands and Wall Street's confidence with an ambitious turnaround...
‘They have no honor’: America’s top pension fund to vote against Elon Musk’s $56 billion pay deal, CEO says
CalPERS, which owns a $1.67 billion stake in Tesla, is set to vote against Musk’s controversial pay deal that was previously voided by a Delaware...
At 40, he thought it was ‘too late’ to attend law school. Now, this father of four is a Yale grad.
“I don’t think many of us are as stuck as we think we are,” Teddy Ray told MarketWatch. Here’s his advice for a midlife career...
Nike has a $28 million decision to make with its Caitlin Clark shoe: Design it for women or make it unisex?
Retail expert says Nike is making a mistake if it doesn’t design the shoe for women’s feet.
‘He found excuse after excuse not to work — yet always managed to play golf’: My husband wants half of my $1 million home. What can I do?
“I made all the mortgage payments, in addition to paying for health coverage for both of us.”
Writing a retirement résumé? Drop the AOL email and 5 pages of experience, and follow these tips to get hired while retired.
Working in retirement is becoming a necessity for many, how to put your best self forward
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Goldman Sachs started coverage of AstraZeneca at buy as it rated rival GSK a neutral.
Here are the portfolio’s top 5 performing stocks since April’s Monthly Meeting
Nvidia and a couple other AI-related stocks were among the Club's top-performing stocks since our April 24 monthly call.